NYSEMKT: NNVC
Nanoviricides Inc Earnings Dates, Reports, Calls

Nanoviricides earnings were -$8.1M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest NNVC earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$2.0M, down 10.4% from last quarter. For the last reported fiscal year 2025 ending Jun 30, 2025, NNVC reported annual earnings of -$9.5M, with 14.1% growth.

NNVC earnings history

Current Revenue
$0.0
Current Earnings
-$8.1M
Current Profit Margin
0%

NNVC Return on Equity

Current Company
-92.7%
Current Industry
-141.9%
Current Market
13.5%
NNVC's Return on Equity (-92.7%)... subscribe to Premium to read more.
High Return on Equity Performance

NNVC Return on Assets

Current Company
-81.6%
Current Industry
-13.7%
NNVC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when NNVC announces earnings.

NNVC Return on Capital Employed

Current Company
-88.39%
Current Industry
-9.6%
NNVC's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NNVC vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
NNVC-$7.53M-$8.09MN/A-$0.43
PSTV-$11.69M-$11.93MN/A-$1.55
DYAI-$6.84M-$7.29MN/A-$0.23
VTGN-$68.95M-$69.69MN/A-$1.83
KYNB$172.88M$163.62MN/A$40.44

Nanoviricides Earnings Reports & History FAQ

What were Nanoviricides's earnings last quarter?

On NNVC's earnings call on Invalid Date, Nanoviricides (NYSEMKT: NNVC) reported Q1 2026 earnings per share (EPS) of -$0.09, up 35.71% year over year. Total NNVC earnings for the quarter were -$1.99 million. In the same quarter last year, Nanoviricides's earnings per share (EPS) was -$0.14.

If you're new to stock investing, here's how to buy Nanoviricides stock.

Is Nanoviricides profitable or losing money?

As of the last Nanoviricides earnings report, Nanoviricides is currently losing money. Nanoviricides's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$8.09 million, a 16.82% decrease year over year.

What was NNVC's earnings growth in the past year?

As of Nanoviricides's earnings date in Invalid Date, Nanoviricides's earnings has grown year over year. NNVC earnings in the past year totalled -$8.09 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.